The Michigan Center for Therapeutic Innovation (MCTI) and Fast Forward Medical Innovation (FFMI) offer a five-year, $2.5 million fund created to accelerate the discovery and translation of therapeutic candidates at the University of Michigan. The fund supports the discovery and optimization of small molecule lead compounds for projects with a specific, novel, and testable drug discovery hypothesis. Selected projects receive funding and resources from MCTI in the areas of drug design, cell biology, medicinal chemistry, structural biology, and pharmacology (up to $150,000 in value for each award for up to 18 months).
A pre-submission application and meeting must be completed on or before August 25, 2017
The submission deadline for the full proposal will be on Friday, September 8, 2017, at 5 pm EST
Potential applicants are strongly encouraged to contact Ester Fernandez-Salas at firstname.lastname@example.org or 734-998-8301, or Visha Krishnan at email@example.com or 734-764-2891to learn more about the program and to begin work on their application.